文献速递口腔修复与种植

疏水性组织水平锥形种植体骨结合的比较:临床前体内研究

Comparative osseointegration of hydrophobic tissue-level tapered implants-A preclinical in vivo study.
PubMed 文献 · Clin Oral Implants Res · 2024-07-20

本研究在下颌迷你猪模型中比较新型锥形自攻组织水平测试种植体与标准组织水平对照种植体的骨结合及嵴顶骨愈合,评估3、6、12周。测试种植体植入扭矩显著更高(50.0 ± 26.4 Ncm vs 35.2 ± 19.7 Ncm,p = .0071)。骨-种植体接触(BIC)非劣于对照,12周时分别为81.62 ± 11.12%和90.41 ± 4.81%(p = .1763);首次BIC(fBIC)除12周外无差异,12周测试组更低(-675.58 ± 590.88 μm vs -182.75 ± 197.40 μm,p = .0068)。结论为新型自攻组织水平种植体骨结合与嵴顶骨高度维持非劣于对照。

要点

  • 测试种植体植入扭矩显著高于对照(50.0 ± 26.4 Ncm vs 35.2 ± 19.7 Ncm,p = .0071)。
  • BIC在观察期内非劣于对照,12周时81.62 ± 11.12% vs 90.41 ± 4.81%(p = .1763)。
  • fBIC除12周外无统计差异,12周测试组更低(-675.58 ± 590.88 μm vs -182.75 ± 197.40 μm,p = .0068)。

核心结论

  • 新型自攻组织水平种植体骨结合与嵴顶骨高度维持非劣于对照种植体。

研究设计与样本

  • 下颌迷你猪模型,植入种植体后于3、6、12周进行组织形态学评估,比较测试与对照种植体。

主要发现

  • 测试种植体植入扭矩显著高于对照(50.0 ± 26.4 Ncm vs 35.2 ± 19.7 Ncm,p = .0071)。
  • 12周BIC测试组81.62 ± 11.12%,对照组90.41 ± 4.81%(p = .1763)。
  • 12周fBIC测试组-675.58 ± 590.88 μm,对照组-182.75 ± 197.40 μm(p = .0068)。

临床怎么用

  • 该临床前结果支持新型自攻组织水平种植体在骨结合方面非劣于标准种植体,但需临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To histometrically compare the osseointegration and crestal bone healing of a novel tapered, self-cutting tissue-level test implant with a standard tissue-level control implant in a submerged healing regimen. MATERIALS AND METHODS: In a mandibular minipig model, implants were inserted and evaluated histometrically after a healing period of 3, 6, and 12 weeks. The primary outcome was the evaluation of bone-to-implant contact (BIC) and secondary outcomes were primary stability as per insertion torque and first BIC (fBIC). Outcomes for the test and control implants were compared using Wilcoxon signed-rank tests and mixed linear regression models. RESULTS: Insertion torque values were significantly higher for the test (50.0 ± 26.4 Ncm) compared to the control implants (35.2 ± 19.7 Ncm, p = .0071). BIC values of test implants were non-inferior to those of control implants over the investigated study period. After 12 weeks, the corresponding values measured were 81.62 ± 11.12% and 90.41 ± 4.81% (p = .1763) for test and control implants, respectively. Similarly, no statistical difference was found for fBIC values, except for the 12 weeks outcome that showed statistically lower values for the test (-675.58 ± 590.88 μm) compared to control implants (-182.75 ± 197.40 μm, p = .0068). CONCLUSIONS: Novel self-cutting tissue-level implants demonstrated noninferior osseointegration and crestal bone height maintenance to the tissue-level implants. Histometric outcomes between both implants demonstrated test implants were statistically noninferior to control implants, despite substantial differences in the bone engagement mechanism and resulting differences in insertion torque and qualitative bone healing patterns.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Imber JC, Khandanpour A, Roccuzzo A, et al. Comparative osseointegration of hydrophobic tissue-level tapered implants-A preclinical in vivo study. Clin Oral Implants Res. 2024. PMID: 39032079. doi:10.1111/clr.14318

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。